Hallmark features of CLL include amplified B-cell receptor (BCR) signaling, defective apoptosis, profound tumor microenvironment (TME) dependency, and immune dysfunction [1,2]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.